Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centreFocke Ziemssen, You-Shan Feng, Sven Schnichels, Tarek Bayyoud, Marius Ueffing, Karl Ulrich Bartz-Schmidt, Peter Martus, Andreas Peter
13 April 2021
Eye-tracking-based visual field analysis (EFA): a reliable and precise perimetric methodology for the assessment of visual field defectsMichael Christian Leitner, Florian Hutzler, Sarah Schuster, Lorenzo Vignali, Patrick Marvan, H A Reitsamer, Stefan Hawelka
17 March 2021
Is an integrated model of school eye health delivery more cost-effective than a vertical model? An implementation research in ZanzibarVing Fai Chan, Fatma Omar, Elodie Yard, Eden Mashayo, Damaris Mulewa, Lesley Drake, Mary Wepo, Hasan Minto
19 January 2021
Cataract surgery practice patterns worldwide: a surveyTommaso Rossi, Mario R Romano, Danilo Iannetta, Vito Romano, Luca Gualdi, Isabella D'Agostino, Guido Ripandelli
13 January 2021
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (vastin) for neovascular macular degeneration in the ast idlandsAlexander Foss, Rebecca Haydock, Margaret Childs, Lelia M Duley, Theo Empeslidis, Sushma Dhar-Munshi, Alan A Montgomery, Reuben Ogollah, Mara Ozolins, Paul Tesha, Eleanor Mitchell
8 December 2020
Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 statesShahina Pardhan, Megan Vaughan, Jufen Zhang, Lee Smith, Havovi Chichger
30 November 2020
Effectiveness and safety of azithromycin 1.5% eye drops for mass treatment of active trachoma in a highly endemic district in CameroonAssumpta Lucienne Bella, Ellen Einterz, Pierre Huguet, Philippe Bensaid, Abdou Amza, Didier Renault
1 November 2020
Clinical safety of a minor eye conditions scheme in England delivered by community optometristsEvgenia Konstantakopoulou, Robert A Harper, David F Edgar, Genevieve Larkin, Sarah Janikoun, John G Lawrenson
20 February 2018